Special
Opportunities for Patient Representatives
Dear Colleague,
Do you represent a 501(c)(3) organization in the United
States or registered charities in Canada that serve constituents with major
chronic diseases and/or rare/orphan diseases?
Then you can’t afford to miss your opportunity to apply for a scholarship to
attend the DIA
2013 49th Annual Meeting as part of the Patient
Advocate Fellowship Program.
Through the Patient Advocate Fellowship Program, DIA is working to ensure
that the "voice of the patient" is heard globally in every facet of the life
cycle management of pharmaceuticals, medical devices, and related health care
products.
Twenty patient representatives, chosen through a competitive process, will
have opportunities to develop, strengthen, and support collaborations with
policymakers, industry, academia, and health professionals by taking part in all
facets of DIA 2013 49th Annual Meeting in Boston.
What is the Patient Advocate
Fellowship Program? The DIA Patient Advocate Fellowship
Program is designed to: • Develop, strengthen, and support patient
collaborations with policy makers, health professionals, industry
representatives, and academia • Increase the knowledge and understanding
of patient groups about key issues central to patient-centered health
care, biomedical research, and drug development • Develop the capacity
of patient groups to advocate for change • Improve alliances between
patient groups and other health care stakeholders • Stimulate
cooperation, promote dialogue, and share best practices
Hear more about DIA's Patient Advocate
Fellowship Pogram:
DIA 2012 48th Annual Meeting Participating
Organizations: |
• ARPKD/CHF
Alliance • Averys Angels Gastroschisis Foundation • Canadian
Organization for Rare Disorders • Cholangiocarcinoma Foundation
• HepTREC • Huntington's Disease Society of America •
International Cancer Advocacy Network • International WAGR Syndrome
Association • Lupus Foundation of America • Mass General Cancer
Center |
• Mastocytosis Society •
MRSA Survivors Network • National Alliance for Medication Assisted
Recovery • National Dysautonomia Research Foundation • Nueva Vida (Latin
Women with Cancer) • Ovarian Cancer National Alliance • Soft Bones •
Sturge-Weber Foundation • United Nations Bone and Joint Decade •
Vestibular Disorders Association |
What is the DIA 2013 49th Annual
Meeting?DIA
2013 49th Annual Meeting connects all partners involved in bringing new
therapies to patients. Historically, this enterprise has focused on drug
development, but today those partners include a very diverse range of
stakeholders from biotechnology, diagnostics, and medical device companies, to
regulatory agencies, scientific and academic communities, service payers and
providers, and patient organizations. See
for Yourself What Others Say about the DIA Annual Meeting...
Global Patient
InitiativesPatient organizations are key stakeholders in
DIA’s mission to foster innovation to improve health and well-being worldwide.
Find
out how you can make an impact as a patient group representative.
Special Discount for Patient Organizations:
DIA offers another opportunity for patient organizations at
the Annual Meeting by offering registration for only $250,
which includes a one-year complimentary e-membership. Proof of 501 (c)(3) status
required. Download the registration form.
Keynote Speaker: Daniel
Kraft, MD Executive Director,
FutureMedHear
from Dr. Kraft regarding the DIA 2013 49th Annual Meeting
|
No comments:
Post a Comment